Multiple Myeloma Comprehensive Profile Test
Understanding Multiple Myeloma Diagnosis
Multiple myeloma is a complex hematologic malignancy characterized by the uncontrolled proliferation of plasma cells in the bone marrow. Our Comprehensive Multiple Myeloma Profile represents the gold standard in diagnostic testing, combining multiple advanced laboratory techniques to provide a complete picture of disease status, progression, and treatment response.
What This Comprehensive Test Measures
The Multiple Myeloma Comprehensive Profile integrates multiple diagnostic components to deliver unparalleled insights:
- Complete Blood Count (CBC): Evaluates red blood cells, white blood cells, and platelets for anemia and other abnormalities
- Kidney Function Assessment: Urea and creatinine measurements to detect renal impairment
- Calcium and Albumin Levels: Monitors for hypercalcemia, a common complication
- Protein Electrophoresis: Identifies monoclonal proteins (M-proteins) in serum
- Immunotyping and Immunoglobulin Profile: Characterizes specific antibody abnormalities
- Kappa/Lambda Light Chain Analysis: Detects light chain ratios for disease monitoring
- Beta-2 Microglobulin: Important prognostic marker for disease staging
- Minimal Residual Disease (MRD) Detection: Advanced flow cytometry to detect remaining cancer cells after treatment
Who Should Consider This Test?
This comprehensive profile is recommended for individuals experiencing:
- Unexplained bone pain, particularly in the back or ribs
- Persistent fatigue and weakness
- Recurrent infections or frequent illnesses
- Unexplained weight loss
- Kidney function abnormalities
- High calcium levels detected in routine blood work
- Anemia without clear cause
- Family history of multiple myeloma or related blood disorders
Clinical Benefits of Comprehensive Testing
Choosing our Multiple Myeloma Comprehensive Profile provides numerous advantages:
- Early Detection: Identifies disease in early stages when treatment is most effective
- Accurate Staging: Provides critical information for determining disease severity
- Treatment Monitoring: Tracks response to therapy and detects relapse early
- Prognostic Information: Helps predict disease course and treatment outcomes
- Comprehensive Assessment: Single test provides multiple data points for complete evaluation
- Minimal Residual Disease Detection: Advanced technology to detect remaining cancer cells
Understanding Your Test Results
Your comprehensive test results will be interpreted by our expert oncology team:
- Normal Results: Indicate no evidence of multiple myeloma or related disorders
- Abnormal Protein Patterns: May suggest monoclonal gammopathy or early myeloma
- Elevated Light Chains: Can indicate active disease requiring treatment
- MRD Positive: Detection of minimal residual disease may guide maintenance therapy
- Kidney Impairment Markers: May indicate myeloma kidney involvement
All results are reviewed by board-certified oncologists who provide detailed explanations and recommendations for next steps.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing with rapid turnaround times.
Advanced Testing Methodology
Our Multiple Myeloma Comprehensive Profile utilizes cutting-edge laboratory techniques:
- Capillary Electrophoresis: Precise protein separation and quantification
- Flow Cytometry: Advanced cell analysis for MRD detection
- Immunoturbidimetry and Nephelometry: Accurate immunoglobulin measurement
- Spectrophotometry: Reliable biochemical analysis
- Electrical Impedance: Automated cell counting technology
Sample Requirements and Preparation
For optimal results, please follow these preparation guidelines:
- Sample Collection: 5 mL serum from SST tube AND 3 mL whole blood in EDTA tube
- Bone Marrow Samples: 3 mL bone marrow aspirate in sodium heparin tube with unstained smears
- Fasting: Overnight fasting is preferred for accurate results
- Shipping: Refrigerated transport with proper temperature maintenance
- Required Information: Sample time point, previous immunophenotype reports, clinical history including anti-CD38 therapy status
Turnaround Time and Reporting
We offer efficient testing services with samples processed daily by 9 AM and comprehensive reports delivered within 3 working days. Our detailed reports include expert interpretation and clinical recommendations.
Take Control of Your Health Today
Early detection and comprehensive monitoring are crucial for successful multiple myeloma management. Our advanced testing profile provides the detailed information needed for accurate diagnosis and effective treatment planning.
Ready to schedule your Multiple Myeloma Comprehensive Profile Test? Contact our dedicated oncology testing specialists at +1(267) 388-9828 or book your appointment online. Take the first step toward comprehensive cancer care and peace of mind.

